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Abstract 
Pneumonia is an acute infectious disease that attacks lung tissue (alveoli) which can be caused by viral, bacterial, 
or fungal infections. Pneumonia is one of the diseases that have the highest death risk in Indonesia. The first line 
of treatment for pneumonia is antibiotic therapy. Inappropriate use of antibiotics will increase the possibility of 
antibiotic resistance. Antimicrobial Control Program (PPRA) is a health surveillance to control the use of 
antibiotics where the indicator of success is seen from the improvement in the quantity and quality of antibiotic 
use. Antibiotic control that can be performed is evaluating the use of antibiotics quantitatively and evaluating the 
suitability of antibiotics. The purpose of this study was to determine the quantity of antibiotic use with the 
DDD/100 patient-days unit and the suitability of the use of antibiotics based on PPAB. This study was 
observational, the data were taken retrospectively and analyzed descriptively. The research material used 
medical record data for pneumonia patients from January to June 2020 at RSUD Bangil. There were 91 research 
samples obtained by purposive sampling that met the inclusion and exclusion criteria. The data were analyzed 
quantitatively using the DDD/100 patient-days unit and 90% DU, and the suitability of antibiotics was analyzed 
using five indicators of the right indication, the right route, the right dose, the right interval, and the right time of 
administration. The results showed the use of antibiotics with a total value of DDD/100 patient-days of 78.13 
DDD/100 patient-days with the highest value on moxifloxacin (39.28 DDD/100 patient-days). Antibiotics 
included in the 90% segment that need to be controlled are parenteral moxifloxacin (50.27%), ceftriaxone 
(23.34%), azithromycin (6.83%), oral moxifloxacin (4.62%), and levofloxacin (3.85%). The suitability of 
antibiotics based on PPAB RSUD Bangil 2019 showed the right indication (51.65%), right route (100%), right 
dose (87.23%), right interval (48.93%), and right time of administration (10.64). %). 
 
 




Pneumonia is defined as an infection or acute 
inflammation of the parenchyma or lung tissue, 
especially when the alveoli are filled with fluid and 
puss which will make the patient feel excruciating 
pain so that it is difficult to breathe due to the reduced 
oxygen intake (WHO, 2019). Pneumonia can be 
categorized into two, namely Community-acquired 
Pneumonia (CAP) or community pneumonia and 
Hospital-acquired Pneumonia (HAP) or nosocomial 
pneumonia. The most common pneumonia which has 
the highest mortality rate is the community pneumonia 
with 27% of the cases are caused by viral pathogens 
(human rhinovirus and influenza)  and 14% of the 
cases are caused by bacterial pathogens such as 
Mycoplasma pneumoniae, Chlamydophila 
pneumoniae, and Haemophilus influenzae (Grief & 
Loza, 2018). Pneumonia is one of the most frequent 
reasons for hospitalization (Forum of International 
Respiratory Societies, 2017) .  
Pneumonia is included as the top 10 inpatient 
diseases in hospitals with the case proportion of male 
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(53,95%) and female (46,07%), with the Case Fatality 
Rate (CFR) of 7,6%. The mortality rate in community 
pneumonia patients is less than 5% for outpatients and 
20% for inpatients (PDPI, 2014). Basic Health 
Research in 2013 and 2018 stated that the prevalence 
of Indonesian people who contracted pneumonia 
based on the diagnosis of health workers according to 
the province was 1.8% and 2.0% respectively. 
Meanwhile, the prevalence of pneumonia in East Java 
Province in 2018 was 1,8% which was an increase 
from the year 2013 which was 1,7%.  
Pneumonia can be treated with antibiotic 
therapy. The success of therapy in pneumonia patients 
depends on the patient factors, the bacteria, and the 
use of appropriate and adequate antibiotics (PDPI, 
2014). Along with the increasing cases of pneumonia, 
the intensity of the use of antibiotics also increases. 
This is a global threat to health, especially in terms of 
bacterial resistance to antibiotics. Many bacteria are 
resistant to antibiotics. A study stated that the most 
common bacteria found in patients with pneumonia 
were Gram-negative bacteria and the most common 
type was Acinetobacter baumannii, followed by 
Klebsiella pneumoniae. In contrast, the most common 
species of Gram-positive bacteria was Streptococcus 
viridans found at Dr. Soetomo (Yulia et al., 2020). 
According to the Ministry of Health of the Republic of 
Indonesia 2011, the use of antibiotics in health 
facilities is often inappropriate so that it can lead to 
less effective treatment, increased risk to patient 
safety, high cost of treatment, and widespread 
resistance which is shown by antibiotic resistance 
research on patients with a history of using antibiotics 
for the last 3 months have been shown to increase a 
higher probability of resistance compared to patients 
without a history of antibiotic use during the past 3 
months (Alkindi et al., 2019). Meanwhile, antibiotic 
resistance is influenced by the lack of public 
knowledge about rational use of antibiotics so that 
there are still many patterns of inappropriate use of 
antibiotics (Arrang et al., 2019). In order to improve 
patient compliance in using antibiotics, it is necessary 
to increase patient knowledge. Doctors and 
pharmacists who play an important role in providing 
information to patients, health institutions must also 
provide knowledge about rational antibiotic therapy 
(Wattiheluw et al., 2020). Therefore, the existence of a 
public health surveillance agency is needed to control 
and monitor the use of antibiotics on a regular basis.  
Supervision of the use of antibiotics is needed 
to prevent or reduce the incidence of resistant 
microbes. One of them is the Antimicrobial Control 
Program (PPRA), where the quality indicator of 
success is seen from the improvement in the quantity 
of antibiotic use evaluated using the DDD (Defined 
Daily Dose) unit and the quality of antibiotic use 
evaluated using the Gyssens method (Kementrian 
Kesehatan RI, 2015). In addition, the evaluation on the 
quality of antibiotic use can also be done by adjusting 
antibiotics to the local hospital's Antibiotic Use 
Guidelines (PPAB), which have been regulated 
according to the germ map in the hospital. Evaluation 
of the quantity and quality of antibiotic use in 
hospitals, especially in pneumonia, has not been 
widely studied. Research conducted in 2018-2019 on 
the description of the quantity of antibiotic use in the 
internal medicine ward of RSUD Bangil showed that 
the cephalosporin group (51.41%) was the most 
widely used, while ceftriaxone was the antibiotic with 
the highest DDD/100 patient-days value, namely 
27.79 DDD/100 patient-days, and the research 
recommended that further research be conducted on 
the description of the quality of antibiotic use 
(Rachmawati et al., 2020). 
Based on the descriptions above and 
considering the importance of controlling antibiotic 
resistance in hospitals, reporting the use of antibiotics 
on a regular basis, the high pneumonia findings in 
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Pasuruan district which is reported to reach 80%, and 
being no data related to the evaluation of the use of 
antibiotics in inpatient pneumonia patients in RSUD 
Bangil, this study was conducted to evaluate the 
quantity and suitability of the use of antibiotics  in 
RSUD Bangil. It is a referral government hospital in 
Pasuruan Regency, and it has PPRA in the hospital, 
and the status of the Regional Public Service Agency 
(BLUD) is the reference for development and health 
services in the district. 
METHOD  
This study was conducted in the Medical 
Records Installation section of RSUD Bangil from 
December 2020 to January 2021. The study was 
approved by the Director of RSUD Bangil Number 
445.1/3202/424.072.01/2020, and it obtained the 
Ethical Clearence from the Head of Research Ethics of 
RSUD Bangil Number 445.1/25/424.072.01/2020. 
The data were in the form of medical records of 
pneumonia patients with the code of ICD J18.0 
(Bronchopneumonia) and J18.9 (Pneumonia), and the 
data of antibiotics sales of pneumonia patients from 
January to June 2020 at RSUD Bangil.  
The design of this study was observational, the 
data were collected retrospectively and analyzed 
descriptively. The research material used medical 
record data for pneumonia patients for the period of 
January to June 2020 at RSUD Bangil. 
The number of samples obtained was 533 as 
the total population which was later chosen using 
purposive sampling method, that is, the determination 
of sampling that met the predetermined inclusion and 
exclusion criteria. There were 91 samples that met the 
inclusion and exclusion criteria. The inclusion criteria 
were: (1. Patients with a diagnosis of pneumonia in 
the January-June 2020 period who received antibiotics 
treatment at RSUD Bangil; (2. Patients with medical 
records that contained complete data and clear 
demographic data such as medical record number, 
type of gender, age, date of admission & date of 
discharge from hospital, diagnosis, comorbidities, and 
profile of antibiotic use (amount of drug, name of 
antibiotic, dose, interval, duration of administration, 
and route of administration); (3. Adult patients aged 
18 years. The exclusion criteria were: (1. The patient 
died, was discharged against medical records, or the 
patient was referred to another hospital; (2. The 
patient was using antibiotics but for the treatment of 
other infections. 
Data analysis of the quantity of antibiotic usage 
used the DDD/100 patient-days unit and 90% DU 
(Drug Utilization) method, while the evaluation of the 
suitability of antibiotic use was analyzed based on 
PPAB at RSUD Bangil 2019 with 5 assessment 
indicators, namely the right indication, route, dose, 
interval, and duration of administration. 
 
RESULT AND DISCUSSION  
Demographics of Patient  
The demographics of patients in this study 
were presented descriptively based on gender, age, 
type of hospitalization, pneumonia criteria, reasons for 
leaving the hospital, length of hospitalization, and the 
presence of comorbidities. 
As shown in Table 1, the number of male 
patients (65,93%) is higher than the number of female 
patients. Similar to the previous research, pneumonia 
patients were dominated by male patients (60%) (Ilmi 
et al., 2020).   This can be influenced by the smoking 
habits of the patients where the prevalence of tobacco 
consumption according to the 2018 Riskesdas in males 
(62.9%) is higher than females. This is also supported 
by a systematic study in Spain which stated its 
findings that active smoking in males has a direct and 
indirect effects on pneumonia risk (Almirall et al., 
2017). CAP cases are more severe in males than 
females, leading to higher mortality in males,
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Table 1. Pneumonia Patient Demographic Data in January-June 2020 at RSUD Bangil. 
Characteristics Total (n=91) Percentage (%) 
Sex   
Male 60 65,93% 
Female 31 34,07% 
Age (Years old)   
17-25 4 4,39% 
25-35 6 6,59% 
35-45 9 9,90% 
45-55 19 20,88% 
55-65 23 25,27% 
>65 30 32,97% 
In Patient Category   
Non-ICU Inpatient:   
Regular 89 97,80% 
Intensive (HCU) 2 2,20% 
ICU Inpatient:   
ICU 0 0% 
Pneumonia Criteria   
ICU inpatient:   
VAP Pneumonia 0 0% 
Non-ICU inpatient:   
CAP Pneumonia regular inpatient 85 93,40% 
CAP Pneumonia regular inpatient atypical germs 4 4,40% 
CAP Pneumonia intensive inpatient 2 2,20% 
CAP Pneumonia intensive inpatient with ESBL risk 0 0% 
Nosocomial Pneumonia with no MDRO risk 0 0% 
Nosocomial Pneumonia with MDRO risk 0 0% 
Reason for Leaving the hospital   
Doctor’s clearance (healed) 51 56,04% 
With prescriptions (improving) 40 43,96% 
Referred to other hospital 0 0% 
Deceased <24 hours 0 0% 
Deceased >24 hours 0 0% 
Discharge Against Medical Advice (DAMA) 0 0% 
Length of stay (Day)   
1-5 days 54 59,34% 
6-10 days 35 38,46% 
>10 days 2 2,20% 
Note: ICU: Intensife Care Unit; HCU: High Care Unit; CAP: Community Acquired Pneumonia; VAP: 
Ventilator Associated Pneumonia; ESBL: Extended Beta Lactamases; MDRO: Multidrug Resistent 
Organism. 
 
especially to the elder people (Barbagelata et al., 
2020). This shows that the risk factor for male 
(53.95%) is greater than female in contracting 
pneumonia (PDPI, 2014). The most common age 
group experiencing pneumonia were patients aged >65 
years old. The older the age, the greater the risk factor 
for experiencing pneumonia. This is similar to the 
2013 & 2018 Riskesdas data regarding the highest 
pneumonia cases occurring in the 65-74 years age 
group. In 2018, age 70 years and over occupies the 
highest position of death due to pneumonia (Our 
World Data, 2019). The anatomical and functional 
changes in the respiratory system along with the 
increasing age can contribute to an increase in the 
frequency of pneumonia and lung disease (Hasan & 
Maranatha, 2019). Data were taken during the 
COVID-19 pandemic, but in this study, the majority 
of patients underwent regular non-ICU hospitalization






















Figure 1. Comorbidity of Pneumonia Patient at RSUD Bangil
(97.80%) with criteria for CAP pneumonia or 
community pneumonia as many as 85 cases. There 
were no patients with a diagnosis of COVID-19 
pneumonia, seen from Swab Test data showing 
negative results. Comorbidities influence the condition 
and choice of antibiotic therapy in pneumonia patients 
(Figure 1). The most comorbid for infectious diseases 
was Tuberculosis (17.32%), while for non-infectious 
diseases was heart failure (8.1%). High comorbidities 
in pneumonia with Pulmonary Tuberculosis can be 
minimized by increasing self-care behavior through 
family nursing care, and health workers are expected 
to provide counseling and explanations for TB 
sufferers to improve adherence in taking medication 
(Muhtar, 2016 and Putri et al., 2020). Comorbidity is 
associated with the risk of pneumonia where in 
patients with cardiovascular disease the risk of 
pneumonia increases 3 times (Tambun et al., 2019). 
The results of an observational Systematic Review 
study on 2731 records from an electronic database 
stated that functional disorders, COPD (Chronic 
Obstructibe Pulmonary Disease), chronic bronchitis, 
asthma, and a history of CAP are clear risk factors for 
community pneumonia (Almirall et al., 2017). Of the 
91 patients, there were 51 patients leaving the hospital 
due to doctor's permission (56.04%) and the remaining 
40 patients leaving the hospital because their condition 
improved with a doctor's prescription (43.96%). These 
data indicates that patients should be discharged as 
soon as possible if the clinical condition is stable, 
improving, or there are no medical problems, and the 
environment is safe to continue treatment at home 
(PDPI, 2014). In terms of the length of hospitalization, 
most patients (54) stayed for 1-5 days (59.34%). The 
length of days of hospitalization can affect the 









































































































































































































































































































































































Note: ACKD=Acquired Cystic Kidney Disease; CAD=Coronary Heart Disease; CHF=Congestive Heart Failure; 
CKD=Chronic Kidney Disease; COPD=Chronic Obstructive Pulmonary Disease; HIV=Human Immunodeficiency 
Virus; HF=Heart Failure; HHF=Hypertensive Heart Failure; ISK=Infeksi Saluran Kemih; NSTEMI=Non-ST-
Segment Elevation Myocardial Infection; PJK=Penyakit Jantung Koroner; SOPT=Sindrom Obstruksi Pasca 
Tuberkulosis; TB=Tuberculosis 
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Antibiotics Usage Profile 
In this study, there were 11 types of antibiotics 
with various groups (Table 2). All antibiotics used 
were empirical antibiotic therapy. Empirical therapy 
can be changed to definitive therapy if the type of 
causative bacteria is known through microbiological 
examination or bacterial culture results. These data 
show that moxifloxacin (38.52%) and the 
cephalosporin group were the most widely used 
antibiotics. Similar to the 2015 study at the Klaten "x" 
hospital, it showed ceftriaxone (17.39%) was the most 
widely used antibiotic (Safitri, 2015). Meanwhile, the 
antibiotics in 130 unspecified pneumonia patients 
hospitalized in non-ICU in the Pulmonary Room of 
RSUD Tulungagung for the period January-June 2017 
were levofloxacin IV (62.71%), ceftriaxone (27.21%) 
and cefotaxime (5.67%) (Ilmi et al., 2020). 
Ceftriaxone is a third-generation cephalosporin 
antibiotic that contains  lactam ring in its structure. It 
works by inhibiting the synthesis of bacterial cell 
walls by inhibiting the tetrapeptide cross-linking 
process. The cells will rupture/lysis occurs due to the 
low osmotic pressure of the fluid in the bacteria's body 
(Gallagher & MacDougall, 2011). Factors that affect 
the cephalosporin group such as ceftriaxone are used 
the most because they have a broad spectrum of 
effectiveness on Gram-negative bacteria and Gram-
positive bacteria, making it very suitable for empirical 
therapy in pneumonia patients whose cause is 
unknown. Some health centers use ceftriaxone, which 
is reported to be effective in the treatment of severe 
pneumonia. In addition, ceftriaxone has a longer half-
life so it can be given once a day. Supported by 
research in Kilimanjaro, Tanzania, that ceftriaxone is 
an empiric therapy choice with high use (51.1%) in 
hospitals because it is used as a life-saving drug for 
patients fighting severe infections such as pneumonia 
(Sonda Id et al., 2019). The second factor, based on 
the bacterial map at RSUD Bangil, ceftriaxone has 
10% susceptibility to Gram-positive bacteria such as 
Streptococcus spp which is suitable for the therapy of 
pneumonia in which one of the causative bacteria is 
Streptococcus pneumoniae. 
The most widely used antibiotics after 
discharge from the hospital were cefixime 100 mg 
(27.5%) and cefixime 200 mg (30%) in oral 
preparations with a dosage regimen of 2 x 200 mg a 
day. This antibiotic is called replacement therapy or 
replacement therapy which is done by changing the 
injection drug to oral. Switch therapy can be given if 
hemodynamically stable, clinical symptoms improve, 
able to take oral, & normal gastrointestinal function 
(PDPI, 2014) 
Table 2. Type of Antibiotics used on pneumonia 
patients in January-June 2020 period 
Type of 
Antibiotics 
Category ∑ (n) % 
Moxifloxacin Fluoroquinolones 203 38,52% 
Ceftriaxone Cephalosporin III 182 34,54% 
Ceftazidime Cephalosporin III 24 4,55% 
Cefuroxime Cephalosporin II 23 4,36% 
Metronidazole Nitroimidazole 20 3,80% 
Meropenem Carbapenem 16 3,04% 
Cefotaxime Cephalosporin III 11 2,09% 
Azithromycin Macrolides 16 3,04% 
Levofloxacin Fluoroquinolones 16 3,04% 
Clindamycin Lincosamides 8 1,52% 
Cefixime Cephalosporin III 8 1,52% 
 Total 527 100% 
 
The benefits of switching therapy are improving 
patient comfort and mobility, reducing side effects of 
parenteral use of antibiotics, reducing length of 
hospitalization, reducing administration costs, and 
short recovery time (Irawan et al., 2019). 
Quantitative Evaluation of Antibiotic Use 
Quantitative evaluation using the DDD/100 
patient-days unit aims to determine the assumption of 
the average daily maintenance dose of antibiotic use in 
adults (Kementrian Kesehatan RI, 2011). The quantity 
of antibiotic use in pneumonia patients for the 
January-June 2020 period at RSUD Bangil was 78.13 
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DDD/100 patient-days with a total LOS of 499 days. 
78.13 DDD/100 patient-days means that every one 
patient receives 78.13 DDD antibiotics per day of 
hospitalization. The highest value of DDD/100 
patient-days was on the antibiotic moxifloxacin, which 
was 39.28 DDD/100 patient-days. The drug 
consumption data presented in the DDD is only a 
rough estimate of consumption and is not a definite 
picture of actual use (Kementrian Kesehatan RI, 
2015). Another similar study, namely pneumonia 
patients at the RSUD Jombang in 2019, obtained a 
total value of DDD/100 patient-days of 83.25 
DDD/100 patient-days (Ambami, 2020). When 
compared, the total value of DDD/100 patient-days at 
RSUD Bangil is smaller than the total value of 
DDD/100 patient-days at RSUD Jombang. The DDD 
value can be said to be good if the DDD/100 patient-
days value is smaller, which means that the quantity of 
antibiotic prescribing in hospitals is done wisely and 
selectively. However, if the value of DDD/100 
patient-days is greater, it shows the quantity of 
antibiotic use is not good which can lead to antibiotic 
resistance, so it can be said that the quantity of 
antibiotic use at RSUD Bangil is better. Moxifloxacin 
as the antibiotic with the highest quantity of use can 
be influenced by several factors including having a 
pattern of activity as a bactericidal Concentration 
Dependent, killing power against bacteria depending 
on antibiotic levels (Kementrian Kesehatan RI, 2011), 
high bioavailability in the body of 99% so that it 
becomes the antibiotic of choice for pneumonia 
patients (PDPI, 2014), and is the drug of choice for 
pneumonia patients with kidney disorders or patients 
who did not improve after receiving levofloxacin 
(PPAB RSUD Bangil, 2019). 
The high quantity of antibiotic use needs to be 
controlled in terms of prescription and usage to 
prevent the occurrence of resistance. Antibiotic 
controls that have proven to be effective in managing 
the use of antibiotics more rationally include 
enforcement of policies that prohibit over-the-counter 
antibiotics, antimicrobial stewardship programs, active 
participation of doctors in antibiotic audits, use of 
valid rapid point-of-care tests, promotion of delayed 
antibiotic prescribing strategies, improvement of 
communication skills with more pragmatic patient, 
and study performance in primary care (Lior and 
Bjerrum, 2014). The antibiotics included in the 90% 
segment in this study were parenteral moxifloxacin 
(50.27%), ceftriaxone (23.34%), azithromycin 
(6.83%), oral moxifloxacin (4.62%), and levofloxacin 
(3, 85%). Antibiotics included in the 90% segment are 
indirectly antibiotics that need to be controlled. With a 
90% DU calculation, it is hoped that these antibiotics 
can be used more wisely and selectively. This 
information is expected to be used by health workers 
to reduce the risk of antibiotic resistance. 
 
Evaluation on the suitability of antibiotics use 
Evaluation on antibiotic suitability is carried out to 
reduce the use of injudicious and non-selective 
antibiotics, and to support one of the health programs 
in Indonesia, namely the Antimicrobial Control 
Program (PPRA). Evaluation on the suitability of the 
use of antibiotics in pneumonia patients at RSUD 
Bangil was assessed based on PPAB at the hospital. 
The proper indication in this research was whether 
the indication on the patient and antibiotics used were 
according to the recommendation of the PPAB at 
RSUD Bangil (Table 5).  Forty-seven patients 
(51,65%) were proper indication with the majority 
indication being CAP pneumonia regular inpatient. 
Only these patients (47 patients) carried out to the next 
evaluation on proper indication. There was a 
discrepancy in patients taking meropenem, which 
should be used for pneumonia patients at risk for 
ESBL (Extended Spectrum Beta Lactamase). 
Meanwhile, according to the American Thoracic 
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Society, meropenem is used for CAP pneumonia with 
a risk of Pseudomonas infection. The results of 
bacterial culture became the limitation so that the 
assessment was only seen from empirical therapy. 
Levofloxacin was chosen as pneumonia therapy 
because of its susceptibility to Gram-negative bacteria 
such as Enterobacteriacea (44%), Burkholderia 
cepacia (46%), Stenotrophomonas spp. (50%), and 
Other non Enterobacteriaceae (44%). While in Gram-
positive bacteria, 10% was susceptible to 
Streptococcus spp. Ceftriaxone has a susceptibility 
value to Streptococcus spp. 10% and 
Enterobacteriacea 50% (PPAB RSUD Bangil, 2019).  
Proper route. The 47 samples showed 100% proper 
route which means that all patients received a proper 
route of antibiotics. Parenteral route (P) is used the 
most because it has the fastest therapy response, it is 
easy to administer to patients having difficulty in 
swallowing, it has a higher bioavailability than the 
oral route (O), and it is safe for patients with 
gastrointestinal problems (Stein, 2015).  
Table 3. Value of DDD/100 patient-days 












J01DC02 Cefuroxime (P) 22 g 3 g 
499 days 
1,47 
J01DD01  Cefotaxime (P) 12 g 4 g 0,60 
J01DD02 Ceftazidime (P) 24 g 4 g 1,20 
J01DD04 Ceftriaxone (P) 182 g 2 g 18,24  
J01DD08  Cefixime (O) 1,6 g 0,4 g 0,80 
J01DH02 Meropenem (P) 26 g 3 g 1,74 
J01FA10 Azithromycin (O) 8 g 0,3 g 5,34 
J01FF01  Clindamycin (O) 6,6 g 1,2 g 1,10 
J01MA12  Levofloxacin (P) 7,5 g 0,5 g 3,01 
J01MA12  Levofloxacin (O) 0,5 g 0,5 g 0,20 
J01MA14  Moxifloxacin (P) 78,4 g 0,4 g 39,28 
J01MA14  Moxifloxacin (O) 7,2 g 0,4 g 3,61 
J01XD01  Metronidazole (P) 11,5 g 1,5 g 1,54 
J01XX01  Fosfomycin (P) 66 g 8 g 1,65 
  387,3 g   78,13 
      
Proper dose indicates that only 41 patients (87,23%) 
had the proper dose. The accuracy of the dose is 
related to the concentration dependent, using the right 
dose so that the levels in the body are maximized and 
the antibiotic works optimally (Kementrian Kesehatan 
RI, 2011). Inaccurate dose can affect the success of 
antibiotics, if the dose is too low, the effectiveness of 
antibiotics is not achieved or less than optimal. If the 
dose is too high, there will be a possibility of toxicity. 
Proper interval was given to 23 patients (48.93%), 
17 patients (36.17%) were not proper, and 7 patients 
(14.90%) were not evaluated because the patient's 
medical record data did not record the time of 
administration so that an assessment could not be 
made. The lack of data on the time of administration 
to these patients was caused by the limitations of 
recording in the medical record, so it was necessary to 
study and integrate data with health workers at RSUD 
Bangil, especially notes on the timing of antibiotics. 
The accuracy of the interval is related to the duration 
of antibiotics in the body, Time Dependent 
(Kementrian Kesehatan RI, 2011). Improper intervals 
will give bacteria the opportunity to adapt and 
recognize antibiotics so that when the antibiotic is 
used its effectiveness is reduced or even not at all in 
other words resistance has occurred.   
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Proper duration of administration showed that 5 
patients (10.64%) had the proper duration of 
administration, 18 patients (38.30%) and 24 patients 
(51.06%) had no record of the duration of 
administration which became the limitation in this 
study, namely the administration of cefuroxime and 
ceftriaxone for pneumonia patients at PPAB RSUD 
Bangil 2019 was not known so that an assessment 
could not be carried out. The duration of 
administration for pneumonia patients can vary 
according to the patient's physiological state and the 
presence of comorbidities. The inaccuracy of the 
duration of administration is also influenced by the 
length of hospitalization of the patient which is short 
compared to the recommended duration of antibiotic 
administration. Suggestions that can be given to 
overcome the limitations of recording in medical 
records is to integrate data electronically (Sanjaya & 
Oktavia, 2015). 
 
Table 4. Properness of Antibiotics Use Based on PPAB RSUD Bangil 2019 
Evaluation Total (n=91) Percentage (%) 
Proper Indication   
Proper 47 51,65% 
Improper 44 48,35% 
Evaluation Total (n=47) Percentage (%) 
Proper Route   
Proper 47 100% 
Improper 0 0% 
Proper Dose   
Proper 41 87,23% 
Improper 6 12,77% 
Proper Interval   
Proper 23 48,93% 
Improper 17 36,17% 
Not evaluated 7 14,90% 
Proper Duration of 
Administration 
  
Proper 5 10,64% 
Improper 18 38.30% 
Not Evaluated 24 51,06% 
 
Table 5. Antibiotics Recommendation Based on PPAB RSUD Bangil 2019 
Indication Antibiotics Recommendation Proper Improper 
CAP Pneumonia  
Regular inpatient 
Levofloxacin, Ceftriaxone,  
Cefuroxime, or Cefoperazone 
(Moxifloxacin administered to 
patients with kidney disorder or 
patient not improving after taking 
Levofloxacin) 
43 43 
CAP Pneumonia  
Regular inpatient 
Atypical germs 
Azithromycin, Clarithromycin, or 
Doxycycline 
3 0 




Levofloxacin, Ceftriaxone + 
Levofloxacin, or  
Ceftriaxone+ Azithromycin 
1 1 
 Total (91 patients) 47 patients 44 patients 
 Percentage (100%) 51,65% 48,35% 
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The duration of antibiotic administration is at most 1-3 
days, this can be influenced by the duration of 
antibiotic administration for empirical therapy which 
is within 48-72 hours  (Kementerian Kesehatan RI, 
2011), and the patient is immediately discharged if the 
clinical condition is stable, improving or there are no 
medical problems and the environment is safe to 
continue treatment at home (PDPI, 2014). The 
replacement therapy strategy is combined with a short 
length of hospitalization so that the benefits of therapy 
can be seen (Irawan et al. al., 2019). The short length 
of hospitalization causes the duration of antibiotic use 




The most used antibiotics for pneumonia 
patients in RSUD Bangil based on DDD/100 patient-
days are fluoroquinolone and cephalosporin as Watch 
group antibiotics in AWaRe classification by WHO. 
This group includes antibiotic classes that have higher 
resistance potential which need to be prioritized as key 
targets of stewardship programs and monitoring. A 
successful antibiotic strategy is not only about 
controlling the number, but also about monitoring the 
proper use of antibiotics to improve antibiotic 
treatment, increase access and reduce antimicrobial 
resistance. Having this information in RUSD Bangil 
related to the quantity and quality of antibiotic use, it 
is expected to be an evaluation for the future the 
selection and use of antibiotics can be wiser and more 
selective in prescribing antibiotics by updating germ 
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